Literature DB >> 16775318

The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR.

Andrea Marzi1, Armin Akhavan, Graham Simmons, Thomas Gramberg, Heike Hofmann, Paul Bates, Vishwanath R Lingappa, Stefan Pöhlmann.   

Abstract

The C-type lectins DC-SIGN and DC-SIGNR (collectively referred to as DC-SIGN/R) bind to the ebolavirus glycoprotein (EBOV-GP) and augment viral infectivity. DC-SIGN/R strongly enhance infection driven by the GP of EBOV subspecies. Zaire (ZEBOV) but have a much less pronounced effect on infection mediated by the GP of EBOV subspecies. Sudan (SEBOV). For this study, we analyzed the determinants of the differential DC-SIGN/R interactions with ZEBOV- and SEBOV-GP. The efficiency of DC-SIGN engagement by ZEBOV-GP was dependent on the rate of GP incorporation into lentiviral particles, while appreciable virion incorporation of SEBOV-GP did not allow robust DC-SIGN/R usage. Forced incorporation of high-mannose carbohydrates into SEBOV-GP augmented the engagement of DC-SIGN/R to the levels observed with ZEBOV-GP, indicating that appropriate glycosylation of SEBOV-GP is sufficient for efficient DC-SIGN/R usage. However, neither signals for N-linked glycosylation unique to SEBOV- or ZEBOV-GP nor the highly variable and heavily glycosylated mucin-like domain modulated the interaction with DC-SIGN/R. In contrast, analysis of chimeric GPs identified the signal peptide as a determinant of DC-SIGN/R engagement. Thus, ZEBOV- but not SEBOV-GP was shown to harbor high-mannose carbohydrates, and GP modification with these glycans was controlled by the signal peptide. These results suggest that the signal peptide governs EBOV-GP interactions with DC-SIGN/R by modulating the incorporation of high-mannose carbohydrates into EBOV-GP. In summary, we identified the level of GP incorporation into virions and signal peptide-controlled glycosylation of GP as determinants of attachment factor engagement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775318      PMCID: PMC1488929          DOI: 10.1128/JVI.02545-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR.

Authors:  Yuan Guo; Hadar Feinberg; Edward Conroy; Daniel A Mitchell; Richard Alvarez; Ola Blixt; Maureen E Taylor; William I Weis; Kurt Drickamer
Journal:  Nat Struct Mol Biol       Date:  2004-06-13       Impact factor: 15.369

2.  Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity.

Authors:  Eloísa Yuste; Jacqueline D Reeves; Robert W Doms; Ronald C Desrosiers
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins.

Authors:  Z Yang; R Delgado; L Xu; R F Todd; E G Nabel; A Sanchez; G J Nabel
Journal:  Science       Date:  1998-02-13       Impact factor: 47.728

4.  Processing of the Ebola virus glycoprotein by the proprotein convertase furin.

Authors:  V E Volchkov; H Feldmann; V A Volchkova; H D Klenk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

5.  Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.

Authors:  Kartik Chandran; Nancy J Sullivan; Ute Felbor; Sean P Whelan; James M Cunningham
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

6.  Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

Authors:  Steven M Jones; Heinz Feldmann; Ute Ströher; Joan B Geisbert; Lisa Fernando; Allen Grolla; Hans-Dieter Klenk; Nancy J Sullivan; Viktor E Volchkov; Elizabeth A Fritz; Kathleen M Daddario; Lisa E Hensley; Peter B Jahrling; Thomas W Geisbert
Journal:  Nat Med       Date:  2005-06-05       Impact factor: 53.440

7.  A system for functional analysis of Ebola virus glycoprotein.

Authors:  A Takada; C Robison; H Goto; A Sanchez; K G Murti; M A Whitt; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.

Authors:  R J Wool-Lewis; P Bates
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Context-dependent effects of L domains and ubiquitination on viral budding.

Authors:  Juan Martin-Serrano; David Perez-Caballero; Paul D Bieniasz
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus.

Authors:  Thomas Gramberg; Heike Hofmann; Peggy Möller; Patricia F Lalor; Andrea Marzi; Martina Geier; Mandy Krumbiegel; Thomas Winkler; Frank Kirchhoff; David H Adams; Stephan Becker; Jan Münch; Stefan Pöhlmann
Journal:  Virology       Date:  2005-09-30       Impact factor: 3.616

View more
  36 in total

1.  Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity.

Authors:  Gopi S Mohan; Ling Ye; Wenfang Li; Ana Monteiro; Xiaoqian Lin; Bishu Sapkota; Brian P Pollack; Richard W Compans; Chinglai Yang
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences.

Authors:  John Misasi; Kartik Chandran; Jin-Yi Yang; Bryden Considine; Claire Marie Filone; Marceline Côté; Nancy Sullivan; Giulia Fabozzi; Lisa Hensley; James Cunningham
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

3.  Optimal Expression of the Envelope Glycoprotein of Orthobornaviruses Determines the Production of Mature Virus Particles.

Authors:  Madoka Sakai; Yoko Fujita; Ryo Komorizono; Takehiro Kanda; Yumiko Komatsu; Takeshi Noda; Keizo Tomonaga; Akiko Makino
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

4.  Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.

Authors:  Osvaldo Martinez; Lee Tantral; Nirupama Mulherkar; Kartik Chandran; Christopher F Basler
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  C-type lectins do not act as functional receptors for filovirus entry into cells.

Authors:  Keita Matsuno; Eri Nakayama; Osamu Noyori; Andrea Marzi; Hideki Ebihara; Tatsuro Irimura; Heinz Feldmann; Ayato Takada
Journal:  Biochem Biophys Res Commun       Date:  2010-11-05       Impact factor: 3.575

6.  Cell-cell contact promotes Ebola virus GP-mediated infection.

Authors:  Chunhui Miao; Minghua Li; Yi-Min Zheng; Fredric S Cohen; Shan-Lu Liu
Journal:  Virology       Date:  2015-12-03       Impact factor: 3.616

7.  A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans.

Authors:  Alex S Powlesland; Tanja Fisch; Maureen E Taylor; David F Smith; Bérangère Tissot; Anne Dell; Stefan Pöhlmann; Kurt Drickamer
Journal:  J Biol Chem       Date:  2007-11-05       Impact factor: 5.157

8.  Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2.

Authors:  Chawaree Chaipan; Imke Steffen; Theodros Solomon Tsegaye; Stephanie Bertram; Ilona Glowacka; Yukinari Kato; Jan Schmökel; Jan Münch; Graham Simmons; Rita Gerardy-Schahn; Stefan Pöhlmann
Journal:  Retrovirology       Date:  2010-05-19       Impact factor: 4.602

9.  Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors.

Authors:  Kathrina Quinn; Melinda A Brindley; Melodie L Weller; Nikola Kaludov; Andrew Kondratowicz; Catherine L Hunt; Patrick L Sinn; Paul B McCray; Colleen S Stein; Beverly L Davidson; Ramon Flick; Robert Mandell; William Staplin; Wendy Maury; John A Chiorini
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

10.  Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec.

Authors:  Alessia Ruggieri; Esther Maldener; Marlies Sauter; Nikolaus Mueller-Lantzsch; Eckart Meese; Oliver T Fackler; Jens Mayer
Journal:  Retrovirology       Date:  2009-02-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.